Structure-function relationships of human milk oligosaccharides

Advances in Nutrition

Volumn 3, Issue 3, 2012, Pages

  Bode, Lars ^a   Jantscher Krenn, Evelyn ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; OLIGOSACCHARIDE; SIALIC ACID DERIVATIVE;

ANIMAL; ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CHEMISTRY; DIARRHEA; ENTAMOEBA HISTOLYTICA; ENTEROPATHY; HUMAN; INFANT; METABOLISM; MICROBIOLOGY; NECROTIZING ENTEROCOLITIS; NEWBORN; PARASITOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMATURITY; RAT; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; BREAST FEEDING; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DIARRHEA; ENTAMOEBA HISTOLYTICA; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; INTESTINAL DISEASES; MILK, HUMAN; OLIGOSACCHARIDES; RATS; SIALIC ACIDS;

EID: 84866786695     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.001404     Document Type: Article

References (64)

1. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk:structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722.
2. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad, Ser B, Phys Biol Sci. 2010;86:731-47.
3. German JB, Freeman SL, Lebrilla CB, Mills DA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program. 2008;62: 205-18.
4. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr. 2006;136:2127-30.
5. Kumazaki T, Yoshida A. Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase. Proc Natl Acad Sci USA. 1984;81:4193-7.
6. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, Jelinek J, Stahl B. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr. 2010;104:1261-71.
7. Thurl S, Henker J, Siegel M, Tovar K, Sawatzki G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconj J. 1997;14:795-9.
8. Egge H, Dell A, Von Nicolai H. Fucose containing oligosaccharides from human milk. I. Separation and identification of new constituents. Arch Biochem Biophys. 1983;224:235-53.
9. Coppa GV, Gabrielli O, Zampini L, Galeazzi T, Ficcadenti A, Padella L, Santoro L, Soldi S, Carlucci A, Bertino E, et al. Oligosaccharides in 4 different milk groups, Bifidobacteria, and Ruminococcus obeum. J Pediatr Gastroenterol Nutr. 2011;53:80-7.
10. Johnson PH, Watkins WM. Purification of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase from human milk:an enzyme transferring fucose primarily to type 1 and lactose-based oligosaccharide chains. Glycoconj J. 1992;9:241-9.
11. Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, Giuliani F, Bertin E, Fabris C, Coppa GV. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128:e1520-31.
12. Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T, Kassenborg H, Reilly K, Kennedy M, Angulo F, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004; 15 (38 Suppl 3):S165-74.
13. Marcus R. New information about pediatric foodborne infections:the view from FoodNet. Curr Opin Pediatr. 2008;20:79-84.
14. Fullerton KE, Ingram LA, Jones TF, Anderson BJ, McCarthy PV, Hurd S, Shiferaw B, Vugia D, Haubert N, Hayes T, et al. Sporadic campylobacter infection in infants:a population-based surveillance case-control study. Pediatr Infect Dis J. 2007;26:19-24.
15. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 2003; 278:14112-20.
16. MorrowAL, Ruiz-PalaciosGM, AltayeM, JiangX,GuerreroML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. Humanmilk oligosaccharides are associated with protection against diarrhea in breastfed infants. J Pediatr. 2004;145:297-303.
17. Jantscher-Krenn E, Lauwaet T, Bliss LA, Reed SL, Gillin FD, Bode L. Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. Br J Nutr. Epub 2012 Jan 23.
18. Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc. 2008;83:1154-9.
19. Saffer LD, Petri WA Jr. Entamoeba histolytica:recognition of alphaand beta-galactose by the 260-kDa adherence lectin. Exp Parasitol. 1991;72:106-8.
20. Saffer LD, Petri WA Jr. Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infect Immun. 1991;59:4681-3.
21. Cano-Mancera R, Lopez-Revilla R. Inhibition of the adhesion of Entamoeba histolytica trophozoites to human erythrocytes by carbohydrates. Parasitol Res. 1987;74:18-22.
22. Islam A, Stoll BJ, Ljungstrom I, Biswas J, Nazrul H, Huldt G. The prevalence of Entamoeba histolytica in lactating women and in their infants in Bangladesh. Trans R Soc Trop Med Hyg. 1988;82:99-103.
23. Cummings RD, McEver RP. C-type lectins. In:Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al., editors. Essentials of glycobiology. 2nd ed. New York:Cold Spring Harbor Laboratory Press, 2009.
24. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep paradigm. Cell. 1994;76:301-14.
25. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
26. Rudloff S, Stefan C, Pohlentz G, Kunz C. Detection of ligands for selectins in the oligosaccharide fraction of human milk. Eur J Nutr. 2002;41: 85-92.
27. Rudloff S, Pohlentz G, Diekmann L, Egge H, Kunz C. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr. 1996;85:598-603.
28. Rudloff S, Pohlentz G, Borsch C, Lentze MJ, Kunz C. Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants. Br J Nutr. Epub 2011 Sept 5:1-7.
29. Obermeier S, Rudloff S, Pohlentz G, Lentze MJ, Kunz C. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load. Isotopes Environ Health Stud. 1999;35: 119-25.
30. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost. 2004;92:1402-10.
31. Lühn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69-72.
32. Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Korner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73-6.
33. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, Gershoni-Baruch R. Brief report:recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327: 1789-92.
34. Becker DJ, Lowe JB. Leukocyte adhesion deficiency type II. Biochim Biophys Acta. 1999;1455:193-204.
35. Bode L, Rudloff S, Kunz C, Strobel S, Klein N. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol. 2004;76: 820-6.
36. Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, et al. Platelet/polymorphonuclear leukocyte interaction:P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion:role of PSGL-1 as a signaling molecule. Blood. 1999;93:876-85.
37. Peters MJ, Heyderman RS, Hatch DJ, Klein NJ. Investigation of plateletneutrophil interactions in whole blood by flow cytometry. J Immunol Methods. 1997;209:125-35.
38. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol. 1999;106:391-9.
39. Stefanutti G, Lister P, Smith VV, Peters MJ, Klein NJ, Pierro A, Eaton S. P-selectin expression, neutrophil infiltration, and histologic injury in neonates with necrotizing enterocolitis. J Pediatr Surg. 2005;40:942-7.
40. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL. Necrotizing enterocolitis in very low birth weight infants:biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1991; 119:630-8.
41. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364: 255-64.
42. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health. 1997;87:2026-31.
43. Holman RC, Stoll BJ, Curns AT, Yorita KL, Steiner CA, Schonberger LB. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol. 2006;20:498-506.
44. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F193-8.
45. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotton CM, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156:562-7 e1.
46. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27:428-33.
47. Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 1999;103:1150-7.
48. Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics. 2005; 116:400-6.
49. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336:1519-23.
50. Upperman JS, Potoka D, Grishin A, Hackam D, Zamora R, Ford HR. Mechanisms of nitric oxide-mediated intestinal barrier failure in necrotizing enterocolitis. Semin Pediatr Surg. 2005;14:159-66.
51. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, Beer-Stolz D, Watkins SC, Ford HR. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res. 2000;92:71-7.
52. Guner YS, Franklin AL, Chokshi NK, Castle SL, Pontarelli E, Wang J, Prasadarao NV, Upperman JS, Grishin AV, Ford HR. P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis. Lab Invest. 2011;91:1668-79.
53. Barlow B, Santulli TV. Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery. 1975;77:687-90.
54. Jantscher-Krenn E, Zherebtsov M, Nissan C, Goth K, Guner YS, Naidu N, Choudhury B, Grishin AV, Ford HR, Bode L. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut. Epub 2011 Dec 3.
55. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7:255-66.
56. Sodhi C, Richardson W, Gribar S, Hackam DJ. The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech. 2008;1:94-8.
57. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814-9.
58. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138:1091-5.
59. Westerbeek EA, van den Berg A, Lafeber HN, Fetter WP, van Elburg RM. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo-and acidic oligosaccharides on intestinal permeability in preterm infants. Br J Nutr. 2011;105:268-74.
60. Westerbeek EA, Morch E, Lafeber HN, Fetter WP, Twisk JW, Van Elburg RM. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants. Pediatr Res. 2011;69:255-8.
61. Westerbeek EA, Hensgens R, Mihatsch W, Boehm G, Lafeber H, van Elburg R. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Acta Paediatr. 2011;100:1426-31.
62. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr. 2009;29:177-222.
63. Kuntz S, Rudloff S, Kunz C. Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br J Nutr. 2008;99:462-71.
64. Kuntz S, Kunz C, Rudloff S. Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells. Br J Nutr. 2009;101:1306-15.